期刊文献+

宫颈癌及癌前病变患者HPV感染与机体免疫状态的研究 被引量:15

HPV infection and immune status in cervical carcinoma and cervical intraepithelial neoplasia
下载PDF
导出
摘要 目的探讨宫颈癌及癌前病变患者HPV感染及全身细胞免疫功能状态。方法选择2014年8月至2015年1月妇产科门诊就诊的宫颈癌及癌前病变患者271例,进行液基细胞学(TCT)、HPV-DNA和阴道镜下病理检查,同时行流式细胞术检测外周血淋巴细胞亚群。结果宫颈炎、宫颈上皮内瘤变Ⅰ级(CINⅠ)、宫颈上皮内瘤变Ⅱ级(CINⅡ)、宫颈上皮内瘤变Ⅲ级(CINⅢ)及宫颈鳞状细胞癌(SCC)患者随着宫颈病变程度的加重,HPV阳性率明显升高(P<0.05);随着病理分期的进展,HPV阳性率也明显升高(P<0.01)。CINⅠ、CINⅡ、CINⅢSCC组CD3^+T细胞比例与宫颈炎组比较差异均无统计学意义(均P>0.05),CD4^+T细胞比例逐渐下降,且SCC组与宫颈炎组相比有统计学差异(P<0.05),而CD8^+T细胞比例有逐渐增加的趋势,且CINⅡ、CINⅢ、SCC组与宫颈炎组相比均有统计学差异(均P<0.05)。SCC及CINⅠ、CINⅡ、CINⅢ组CD19^+B细胞比例比较差异均无统计学意义(均P>0.05),而NK细胞比例的差异与宫颈炎组比较均有统计学意义(均P<0.05),且随着病理分期进展逐渐递增。结论宫颈病变患者体内存在明显的淋巴细胞亚群偏移,可能与HPV病毒逃避免疫监视有关,了解这一变化可为免疫治疗干预癌前病变提供帮助。 Objective To investigate HPV infection and immune status in squamous cervical carcinoma (SCC) and cervical intraepithelial neoplasia (CIN). Methods Two hundred and seventy one patients with cervical lesions visiting outpatient department from August 2014 to January 2015 were included in the study. TCT, HPV-DNA tests and colposcopic cervical biopsies were performed, and peripheral blood lymphocyte subsets were examined with flow cytometry in all patients. Results In patients with chronic cervicitis, CIN Ⅰ , CIN Ⅱ, CIN Ⅲ and SCC the positives of HPV expression were increased with the progress of cervical diseases (P〈0.05). And with the progress of the pathological staging, the positive rates of HPV were increased (P〈0.01). There was no significant difference in CD3^+ T-lymphocytes among chronic cervicitis, CIN and SCC (all P 〉 0.05). CD4^+ T-lymphocytes were decreased with the progress of cervical diseases(P〈0.05), while CD8^+ T-lymphocytes were increased(allP〈0.05). There was no significant difference in CD19^+ B-lymphocytes(all P 〉0.05), while significant difference in NK cells among different cervical diseases(all P〈0.05), the degree of positivity was correlated with clinicopathological stages. Conclusion HPV infection rate is increased with the progress of cervical lesions, which is associated with the decreased immune status of patients.
出处 《浙江医学》 CAS 2015年第19期1578-1581,共4页 Zhejiang Medical Journal
关键词 液基细胞学 宫颈上皮内瘤样病变 宫颈癌 淋巴细胞亚群 TCT HPV-DNA Cervical intraepithelial neoplasia Cervical carcinoma Lymphocyte subsets
  • 相关文献

参考文献10

二级参考文献59

  • 1李力.宫颈癌与人乳头瘤病毒感染[J].中国实用妇科与产科杂志,2006,22(1):13-15. 被引量:35
  • 2杨英捷,赵健,李雪倩,廖秦平.2285例女性下生殖道人乳头状瘤病毒感染筛查结果分析[J].中国实用妇科与产科杂志,2006,22(6):444-445. 被引量:95
  • 3Walboomers J M,Jacobs M V,Manos M M,et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol,1999,189(1):12-19.
  • 4Clifford G M,Smith J S,Plummer M,et al.Human papillomavirus types in invasive cervical cancer worldwide:a metaanalysis[J].Br J Cancer,2003,88(1):63-73.
  • 5Duttagupta C,Sengupta S,Roy M,et al.Oncogenic human papillomavirus (HPV) infection and uterine cervical cancer:a screening strategy in the perspective of rural India[J].Eur J Cancer Prev,2002,11(5):447-456.
  • 6Lee G Y,Kin S M,Rim S Y,et al.Human papilloma virus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions[J].Int J Gynecol Cancer,2005,15(1):81-87.
  • 7Rol ó n P A,Smith J S,Munoz N,et al.Human papillomavirus infection and invasive cervical cancer in Paraguay[J].Int J Cancer,2000,85(4):486-491.
  • 8Munoz N,Bosch M K,Castellsague X,et al.Against which human papillomavirus types shall we vaccinate and screen? The international perspective[J].Int J Cancer,2004,111 (2):278-285.
  • 9Broomall E M,Reynolds S M,Jacobson R M.Epidemiology,clinical manifestations,and recent advances in vaccination against human papillomavirus[J].Postgrad Med,2010,122(2):121-129.
  • 10Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer [J ]. CA Cancer J Clin, 2002,52 (6) : 342-362.

共引文献91

同被引文献135

引证文献15

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部